Dixie Huntley

INCLIVA Health Research Institute

Papers

1

Total Citations

11

H-Index

1

About

Dixie Huntley is a leading molecular diagnostics researcher whose work has been pivotal in improving the accuracy of SARS-CoV-2 testing. Her primary research focuses on virology, assay validation, and the optimization of real-time RT-PCR methodologies. Huntley’s most notable contribution is her seminal 2020 study on the amplification of the human β-glucuronidase gene as an internal control to appraise the accuracy of negative SARS-CoV-2 RT-PCR results from upper respiratory tract specimens. This work directly addressed a critical clinical challenge—the high rate of false negatives in early COVID-19 diagnosis—by providing a robust method to distinguish true negatives from inadequate samples. With 11 citations, this paper has become a key reference for laboratories seeking to reduce diagnostic errors. Huntley’s research has enhanced the reliability of viral detection, directly impacting patient management and infection control during the pandemic. Her achievements demonstrate a commitment to bridging the gap between laboratory science and real-world clinical application, making her a valuable voice in the field of infectious disease diagnostics.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens
11 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: INCLIVA Health Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago